SCHEMBL21038238

SCHEMBL21038238

C/C=C1/CN(C)C/C1=C/CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13559968 0.72 — —
SCHEMBL20844305 0.69 — —
SCHEMBL18250279 0.69 PTGS2 (0.47) —
SCHEMBL21476746 0.68 — —
SCHEMBL21119068 0.67 — —
SCHEMBL25592812 0.67 — —
SCHEMBL20804829 0.67 — —
SCHEMBL17988191 0.65 CYP1A2 (0.36) —
SCHEMBL24130319 0.64 — —
SCHEMBL14566025 0.61 EGFR (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104289-A1 PYRROLOBENZODIAZEPINE ANTIBODY CONJUGATES MERSANA THERAPEUTICS, INC. (US) 2019-05-31 — — WO disclosed
Send feedback